The DOI matches its Crossref record; 104 of the 106 references it cites were found in a registry or an index.
Angelman syndrome: insights into genomic imprinting and neurodevelopmental phenotypes
Open accessAbstract
Angelman syndrome (AS) is a severe genetic disorder caused by mutations or deletions of the maternally inherited UBE3A gene. UBE3A encodes an E3 ubiquitin ligase that is expressed biallelically in most tissues but is maternally expressed in almost all neurons. In this review, we describe recent advances in understanding the expression and function of UBE3A in the brain and the etiology of AS. We highlight current AS model systems, epigenetic mechanisms of UBE3A regulation, and the identification of potential UBE3A substrates in the brain. In the process, we identify major gaps in our knowledge that, if bridged, could move us closer to identifying treatments for this debilitating neurodevelopmental disorder.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similarly, paternal-specific deletion of multiple imprinted, paternally expressed genes on the 15q11–q13 region results in Prader–Willi syndrome, whereas maternal deletion of a single, imprinted, maternally expressed gene encoding a ubiquitin-protein ligase (UBE3A) on this same region gives rise to the Angelman syndrome phenotype.”
From Gene × Environment Interactions in Autism Spectrum Disorders: Role of Epigenetic Mechanisms (2014) · cites this paper as [194]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
RING Domain E3 Ubiquitin Ligases
Deshaies, R. J., & Joazeiro, C. A. P. (2009) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.78.101807.093809 · Cited by 2,679
The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53
Scheffner, M., Huibregtse, J. M., Vierstra, R. D., & Howley, P. M. (1993) · Cell · doi:10.1016/0092-8674(93)90384-3 · Cited by 2,416
Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry
Kravitz, A. V., Freeze, B. S., Parker, P. R. L., Kay, K., Thwin, M. T., Deisseroth, K., & Kreitzer, A. C. (2010) · Nature · doi:10.1038/nature09159 · Cited by 1,885
Advances in autism genetics: on the threshold of a new neurobiology
Abrahams, B. S., & Geschwind, D. H. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2346 · Cited by 1,866
UBE3A/E6-AP mutations cause Angelman syndrome
Kishino, T., Lalande, M., & Wagstaff, J. E. (1997) · Nature Genetics · doi:10.1038/ng0197-70 · Cited by 1,304
Lyford, G. L., Yamagata, K., Kaufmann, W. E., Barnes, C. A., Sanders, L. K., Copeland, N. G., Gilbert, D. J., Jenkins, N. A., Lanahan, A. A., & Worley, P. F. (1995) · Neuron · doi:10.1016/0896-6273(95)90299-6 · Cited by 1,212
Physiological functions of the HECT family of ubiquitin ligases
Rotin, D., & Kumar, S. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2690 · Cited by 1,105
Huibregtse, J. M., Scheffner, M., & Howley, P. M. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb04990.x · Cited by 879
De novo truncating mutations in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndrome
Matsuura, T., Sutcliffe, J. S., Fang, P., Galjaard, R. H., Jiang, Y., Benton, C. S., Rommens, J. M., & Beaudet, A. L. (1997) · Nature Genetics · doi:10.1038/ng0197-74 · Cited by 858
Jiang, Y.-H., Armstrong, D., Albrecht, U., Atkins, C. M., Noebels, J. L., Eichele, G., Sweatt, J. D., & Beaudet, A. L. (1998) · Neuron · doi:10.1016/s0896-6273(00)80596-6 · Cited by 852
Cited by
Sorted by citations
Items 201–263 of 263
Persad, R. A., & Ranasinghe, W. (2013) · InTech eBooks · doi:10.5772/56665 · Cited by 3
Toward Personalized Cell Therapies by Using Stem Cells
Isobe, K.-I., Cheung, H. S., & Wu, J. (2012) · BioMed Research International · doi:10.1155/2012/172564 · Cited by 3
Cobalamins Function as Allosteric Activators of an Angelman Syndrome‐Associated UBE3A/E6AP Variant
Müller, F., Jansen, J., Offensperger, F., Eichbichler, D., Stengel, F., & Scheffner, M. (2024) · ChemBioChem · doi:10.1002/cbic.202400184 · Cited by 2
Mechanism of parent-of-origin effects revealed by multi-omic data in euro-chinese hybrid pigs
Li, C., Ge, M., Long, K., Han, Z., Li, M., Zhang, Z., & Huang, L. (2025) · Nature Communications · doi:10.1038/s41467-025-62243-6 · Cited by 2
Variations on a Theme: Crispr Models for 15q11-Q13 Disorders and Beyond
Bailus, B. J. (2014) · Brain Disorders & Therapy · doi:10.4172/2168-975x.1000146 · Cited by 2
Mathews, J. M., Cook, E. K., Margolis, S. S., & Williams, C. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813955-4.00024-6 · Cited by 4
A Scalable, Cell-Based Method for the Functional Assessment of Ube3a Variants
Stelzer, J. A., & Yi, J. J. (2022) · Journal of Visualized Experiments · doi:10.3791/64454 · Cited by 3
Prader–Willi and Angelman syndromes
Smith, E. Y., & Resnick, J. L. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781107360556.019 · Cited by 2
Hang, X., Shang, A., Zhao, Q.-J., Bai, S., Cheng, C., Tao, B., Wang, L.-K., Liang, S., & Yin, L. (2016) · Neural Regeneration Research · doi:10.4103/1673-5374.189200 · Cited by 2
The Genetic and Genomic Landscape of Human Reproductive Disorders: An Overview with Our Experience
Halder, A., Sharma, P., Rana, R., Kalsi, A. S., Jain, M., & Sharma, M. (2023) · Medical Research Archives · doi:10.18103/mra.v11i3.3731 · Cited by 1
Ahmad, S. R., AlShahrani, A. M., & Kumari, A. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00458 · Cited by 1
UBE3A isoform-selective and non-selective contributions to Angelman syndrome phenotypes
Krzeski, J. C., Mientjes, E., Judson, M. C., Dong, G., Hipp, R. I., Lien, K. H., Gu, B., Philpot, B. D., & Elgersma, Y. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03468-9 · Cited by 1
Self-citationEmerging Therapies for Angelman Syndrome
Tychon, C., Markati, T., Alkan, S., Brande, L. V., & Servais, L. (2026) · CNS Drugs · doi:10.1007/s40263-026-01313-9 · Cited by 1
Long Noncoding RNA in Epigenetic Gene Regulation
Hasegawa, Y., & Nakagawa, S. (2015) · Springer eBooks · doi:10.1007/978-4-431-55576-6_8 · Cited by 1
Contributions of neuroimaging to understand childhood epileptic encephalopathies
Griškova-Bulanova, I., Lee, K., Chen, P.-C., Kleineschay, T., Cook, J. C., Schaal, A., Castillo, E., & Korostenskaja, M. (2015) · Journal of Pediatric Epilepsy · doi:10.3233/pep-14087 · Cited by 1
Williams, C. A., & Mueller, J. M. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-410529-4.00020-6 · Cited by 1
Vitrification of oocytes: Imprinting and disturbance in spindle formation and chromosome segregation
Trapphoff, T. (2015) · CRC Press eBooks · doi:10.1201/b19316-17 · Cited by 1
Fetal Epigenetic Origins of Disease
Suter, M., & Aagaard, K. M. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-397175-3.00045-4 · Cited by 1
Prenatal Exposure to Azadiradione Leads to Developmental Disabilities
Jana, S., Das, S., Giri, B., Archak, R., Bandyopadhyay, S., & Jana, N. R. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04493-x · Cited by 1
Ubiquitin ligase signalling networks shape presynaptic development, function and disease
Borgen, M. A., & Grill, B. J. (2024) · The Journal of Physiology · doi:10.1113/jp286469 · Cited by 1
Russo, S., Mainini, E., Luoni, C., Cogliati, F., Giorgini, V., Bonati, M. T., Forzano, F., Termine, C., Murgia, A., Patrini, M., et al. (2015) · Journal of Intellectual Disability - Diagnosis and Treatment · doi:10.6000/2292-2598.2015.03.03.2 · Cited by 1
Brusco, A., & Ferrero, G. B. (2019) · Springer eBooks · doi:10.1007/978-3-030-26276-1_2 · Cited by 2
Progress Toward Therapies and Interventions for Neurodevelopmental Disorders
Ajetunmobi, A., & Tropea, D. (2015) · Wiley eBooks · doi:10.1002/9781118524947.ch14 · Cited by 1
Epigenetics in Brain Development and Disease
Radford, E. J., Ferguson‐Smith, A. C., & Ferrón, S. R. (2017) · Wiley eBooks · doi:10.1002/9781118540770.ch14 · Cited by 1
Understanding Developmental Psychopathology: How Useful Are Evolutionary Perspectives?
Leckman, J. F. (2016) · Wiley eBooks · doi:10.1002/9781119125556.devpsy204 · Cited by 1
Betancur, C., & Mitchell, K. J. (2015) · Wiley eBooks · doi:10.1002/9781118524947.ch9 · Cited by 1
Milazzo, C., Narayanan, R., Badillo, S., Wang, S., Almand, R., Mientjes, E., Chamberlain, S. J., Kremer, T., & Elgersma, Y. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.29.615689 · Cited by 1
Filonova, I. (2014) · Digital Commons - University of South Florida (University of South Florida)
Sheffler-Collins, S. I. (2012) · ScholarlyCommons (University of Pennsylvania)
Genomic Imprinting in the Mammalian Brain
Huang, W.-C., & Gregg, C. J. (2013) · Springer eBooks · doi:10.1007/978-4-431-54496-8_12
The function of TCF4 in Pitt-Hopkins syndrome and schizophrenia
Forrest, M. P. (2013) · ORCA Online Research @Cardiff (Cardiff University)
The role of E3 ubiquitin ligase FBXO31-SCF in neuronal morphogenesis
Vadhvani, M. (2013) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-3270
Social dysfunction and mental retardation
Pietropaolo, S., Sluyter, F., & Crusio, W. E. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781107360556.010
Supplementary material to: IMPRINTING GENES ASSOCIATED WITH ENDOMETRIOSIS
Kobayashi, H. (2014)
Review article: IMPRINTING GENES ASSOCIATED WITH ENDOMETRIOSIS
Kobayashi, H. (2014)
'TEST-NEGATIVE ANGELMAN SYNDROME' WITH THYROID DYSFUNCTION: A RARITY BUT A REALITY!
Ali, M. U., Mehmood, A., & Ali, M. A. (2015) · PubMed
' TEST - NEGATIVE ANGELMAN SY NDROME' WITH THYROID DYSFUNCTION: A RARIT Y BUT A REALITY!
Ali, M., Mehmood, A., & Ali, M. A. (2015)
Rigoglio, N. N. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.10.2016.tde-30052016-154726
Maternal Ube3a is Required for Neurotypical Motivational Drive and GABA co-release
Wallace, J. B. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/m272-rx76
[Dental-craniofacial manifestation and treatment of rare diseases in China].
Luo, E., Shi, B., Chen, Q., & Zhou, X. (2019) · PubMed Central · doi:10.7518/hxkq.2019.02.003
Stafstrom, C. E. (2020) · Epiliepsy currents/Epilepsy currents · doi:10.1177/1535759720948440
Genomic imprinting and neurodevelopment
Castillo, I. L. D., Lozano-Ureña, A., & Ferrón, S. R. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-817988-8.00005-1
Genomic imprinting in haemopoietic stem cells and leukemia
Guo, C., & Wu, Y. (2022) · AIP conference proceedings · doi:10.1063/5.0095078
CRISPR technology and its potential role in treating rare imprinting diseases
Nickl, P., Syding, L. A., & Sedláček, R. (2023) · Principles of Gender-Specific Medicine · doi:10.1016/b978-0-323-88534-8.00044-4
Tokunaga, M., & Imamura, T. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1168072
Younger, D. S. (2023) · Handbook of clinical neurology · doi:10.1016/b978-0-323-98818-6.00003-0
PARamrfinder: detecting allele-specific DNA methylation on multicore clusters
Fernández-Fraga, A., González‐Domínguez, J., & Martín, M. J. (2024) · The Journal of Supercomputing · doi:10.1007/s11227-024-05939-8
Mathews, J. M., & Jalazo, E. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-19041-4.00024-8
Fenton, T. A., Petkova, S. P., Adhikari, A., & Silverman, J. L. (2025) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-025-09616-6
Kumari, M. (2025) · Springer eBooks · doi:10.1007/978-981-96-6202-9_14 · Cited by 1
Giri, B., Das, S., Jana, S., & Jana, N. R. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70238
Epigenetic Therapies in Neurological Diseases
Huang, H., Philpot, B. D., & Jiang, Y. (2013) · Epigenetics and human health · doi:10.1007/978-3-642-36827-1_8
Self-citationWu, Y., Zhang, H., Tang, M., Guo, C., Deng, A., Li, J., Wang, Y., Xiao, L., & Yang, G. (2020) · Figshare · doi:10.6084/m9.figshare.12364145
SUBCELLULAR FUNCTIONS OF UBE3A ISOFORMS DRIVE SYNAPTIC DYSFUNCTION IN ANGELMAN SYNDROMEPreprint
Biagioni, M., Baronchelli, F., Monachello, M., Ongaro, C., Fraviga, E., Erreni, M., Folci, A., Pozzi, D., & Fossati, M. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.24.713622
Mécanisme de régulation de l’activité du microARN miR-16 dans le mélanome uvéal
Quéméner, A. M. (2020) · theses.fr (ABES) · doi:10.70675/b6a2cadfz77d7z48b6zb573zaab26d81396e
Neuronal UBE3A loss engages a TNF-driven neuron-to-microglia axis that promotes synapse remodelingPreprint
Yang, X., Zhang, X., & Huang, Y. A. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.27.728269
Role of E3 Ubiquitin Ligases in Oligodendrocyte Health and Disease
Mabb, A. M., Pyaram, D. N., & Samanta, J. (2026) · ASN NEURO · doi:10.1080/17590914.2026.2682220
Self-citationClinical and Genetic Insights into Angelman Syndrome: A Retrospective Study of 26 Cases in Morocco
Ouskri, A., Bouramtane, A., Belghiti, H. D., Ahakoud, M., Bouguenouch, L., & Ouldim, K. (2026) · Journal of Molecular Neuroscience · doi:10.1007/s12031-026-02570-5
Alari, V., Cambria, C., Cesari, C. D., Vimercati, A., Crippa, M., Perego, S., Larizza, L., Tonazzini, I., Antonucci, F., & Russo, S. (2026) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-026-09728-7
Das, S., Giri, B., & Jana, N. R. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.27.747679
Fu, Y., Zhang, Y., Wang, Z., Peng, G., Li, S., Miao, N., & Sun, T. (2026) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.6c00463
Metadata
- Authors
- Mabb, A. M., Judson, M. C., Zylka, M. J., & Philpot, B. D.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Corresponding author
- Zylka, Mark J.
- Philpot, Benjamin D.
- Venue
- Trends in Neurosciences
- Publisher
- Elsevier BV
- Published
- 2011-06
- Volume
- 34
- Issue
- 6
- Pages
- 293-303
- ISSN
- 0166-2236 (ISSN-L)
- PMC
- PMC3116240
- OpenAlex
- W1973485468
- Cited by
- 263
- References
- 106
- Citations by year
- 2026: 9 · 2025: 10 · 2024: 15 · 2023: 15 · 2022: 9 · 2021: 9 · 2020: 21 · 2019: 17 · 2018: 9 · 2017: 15 · 2016: 21 · 2015: 26 · 2014: 31 · 2013: 30 · 2012: 22
- FWCI
- 2.95
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Trends in Neurosciences (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Eye Institute (R01EY018323)
- National Institute of Neurological Disorders and Stroke (R01NS060725, R01NS067688, F32NS067712)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Syndromes and Imprinting
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
- Keywords
- Angelman syndrome, genomic imprinting, UBE3A, E3 ubiquitin ligase, neurodevelopmental disorders, epigenetic regulation
- MeSH terms
- Animals, Brain, Gene Expression Regulation, Humans, Phenotype, Gene Expression, Angelman Syndrome, Genomic Imprinting, Ubiquitin-Protein Ligases, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review